Horizon Kinetics Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472K | Sell |
11,952
-524
| -4% | -$20.7K | 0.01% | 246 |
|
|
2025
Q1 | $376K | Hold |
12,476
| – | – | ﹤0.01% | 255 |
|
|
2024
Q4 | $436K | Buy |
12,476
+524
| +4% | +$18.3K | 0.01% | 245 |
|
|
2024
Q3 | $479K | Sell |
11,952
-524
| -4% | -$21K | 0.01% | 238 |
|
|
2024
Q2 | $595K | Hold |
12,476
| – | – | 0.01% | 203 |
|
|
2024
Q1 | $541K | Hold |
12,476
| – | – | 0.01% | 207 |
|
|
2023
Q4 | $631K | Sell |
12,476
-524
| -4% | -$26.5K | 0.01% | 193 |
|
|
2023
Q3 | $590K | Hold |
13,000
| – | – | 0.01% | 198 |
|
|
2023
Q2 | $533K | Hold |
13,000
| – | – | 0.01% | 210 |
|
|
2023
Q1 | $465K | Buy |
13,000
+5,000
| +63% | +$179K | 0.01% | 219 |
|
|
2022
Q4 | $302K | Hold |
8,000
| – | – | 0.01% | 252 |
|
|
2022
Q3 | $354K | Hold |
8,000
| – | – | 0.01% | 243 |
|
|
2022
Q2 | $296K | Hold |
8,000
| – | – | 0.01% | 271 |
|
|
2022
Q1 | $296K | Hold |
8,000
| – | – | 0.01% | 280 |
|
|
2021
Q4 | $243K | Hold |
8,000
| – | – | 0.01% | 308 |
|
|
2021
Q3 | $268K | Hold |
8,000
| – | – | 0.01% | 296 |
|
|
2021
Q2 | $319K | Hold |
8,000
| – | – | 0.01% | 287 |
|
|
2021
Q1 | $360K | Sell |
8,000
-1,000
| -11% | -$45K | 0.01% | 261 |
|
|
2020
Q4 | $509K | Sell |
9,000
-4,000
| -31% | -$226K | 0.02% | 230 |
|
|
2020
Q3 | $617K | Hold |
13,000
| – | – | 0.02% | 214 |
|
|
2020
Q2 | $766K | Buy |
13,000
+1,000
| +8% | +$58.9K | 0.03% | 181 |
|
|
2020
Q1 | $567K | Sell |
12,000
-200
| -2% | -$9.45K | 0.03% | 199 |
|
|
2019
Q4 | $737K | Hold |
12,200
| – | – | 0.02% | 201 |
|
|
2019
Q3 | $731K | Hold |
12,200
| – | – | 0.02% | 205 |
|
|
2019
Q2 | $784K | Hold |
12,200
| – | – | 0.02% | 203 |
|
|
2019
Q1 | $990K | Buy |
+12,200
| New | +$990K | 0.03% | 170 |
|